Nod-like receptors in the control of intestinal inflammation.

The Nod-like receptor (NLR) family of intracellular pattern recognition molecules plays critical roles in the control of inflammation through the modulation of different signalling pathways, including those dependent on NF-κB and caspase-1-mediated cleavage of interleukin (IL)-1β and IL-18. A number of NLRs or NLR-associated proteins have been genetically associated with susceptibility to inflammatory bowel disease (IBD), either Crohn's disease or ulcerative colitis. Accordingly, recent studies have examined the role of NLR proteins in chemical-induced or bacteria-induced murine models of colitis. In this review, we will discuss the genetic associations of NLRs with IBD and the research using NLR-deficient mice in different colitis models.

[1]  C. Grangette,et al.  Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide , 2011, Gut.

[2]  P. Pini,et al.  Early online publication , 2002, The Lancet.

[3]  H. Herfarth,et al.  The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer , 2010, The Journal of experimental medicine.

[4]  Joshua M. Korn,et al.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.

[5]  Tariq Ahmad,et al.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 , 2011, Nature Genetics.

[6]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[7]  M. Kastan,et al.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.

[8]  Xia Li,et al.  Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis. , 2010, World journal of gastroenterology.

[9]  M. Fredrikson,et al.  Combined Polymorphisms in Genes Encoding the Inflammasome Components NALP3 and CARD8 Confer Susceptibility to Crohn's Disease in Swedish Men , 2009, The American Journal of Gastroenterology.

[10]  B. Finlay,et al.  Role of Inflammasomes in Host Defense against Citrobacter rodentium Infection* , 2012, The Journal of Biological Chemistry.

[11]  S. Werner,et al.  Active Caspase-1 Is a Regulator of Unconventional Protein Secretion , 2008, Cell.

[12]  V. Dixit,et al.  Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella , 2010, The Journal of experimental medicine.

[13]  Jeffrey N. Weiser,et al.  Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.

[14]  S. Girardin,et al.  Innate IL-17 and IL-22 responses to enteric bacterial pathogens. , 2012, Trends in immunology.

[15]  J. Hugot,et al.  CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice , 2007, PloS one.

[16]  T. Sørensen,et al.  Familial occurrence of inflammatory bowel disease. , 1991, The New England journal of medicine.

[17]  Mathieu Lemire,et al.  Common variants in the NLRP3 region contribute to Crohn's disease susceptibility , 2009, Nature Genetics.

[18]  N. Warner,et al.  The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. , 2011, Immunity.

[19]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[20]  H. Drummond,et al.  Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy. , 2007, Human molecular genetics.

[21]  A. Gruber,et al.  Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis , 2007, Nature.

[22]  Maria Karlsson,et al.  Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. , 2010, Cell host & microbe.

[23]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[24]  M. Zasloff,et al.  Authors' response , 2011, Gut.

[25]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[26]  D. Green,et al.  The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. , 2011, Cancer cell.

[27]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[28]  J. Bertin,et al.  A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis , 2011, The Journal of Immunology.

[29]  E. Elinav,et al.  Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4 , 2010, Proceedings of the National Academy of Sciences.

[30]  Tomohiro Watanabe,et al.  Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. , 2006, Immunity.

[31]  J. Thompson,et al.  Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. , 1993, Gut.

[32]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[33]  Yan Li,et al.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis , 2011, Inflammatory bowel diseases.

[34]  F. Bredin,et al.  Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel , 2011, Inflammatory bowel diseases.

[35]  G. Núñez,et al.  Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the Pathogen , 2011, The Journal of Immunology.

[36]  N. Salzman,et al.  Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum , 2010, Proceedings of the National Academy of Sciences.

[37]  D. Philpott,et al.  Commensal and Probiotic Bacteria Influence Intestinal Barrier Function and Susceptibility to Colitis in Nod1−/−;Nod2−/− Mice , 2012, Inflammatory bowel diseases.

[38]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[39]  R. Kaul,et al.  Identification of an innate T helper type 17 response to intestinal bacterial pathogens , 2011, Nature Medicine.

[40]  H. Drummond,et al.  Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe# , 2007, Inflammatory bowel diseases.

[41]  A. Griffiths,et al.  Genetic profiling in inflammatory bowel disease: from association to bedside. , 2011, Gastroenterology.

[42]  J. Tschopp,et al.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.

[43]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[44]  M. Chamaillard,et al.  Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury , 2011, Proceedings of the National Academy of Sciences.

[45]  T. Karlsen,et al.  No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population , 2006, Gut.

[46]  N. Warner,et al.  Cutting Edge: Crohn’s Disease-Associated Nod2 Mutation Limits Production of Proinflammatory Cytokines To Protect the Host from Enterococcus faecalis-Induced Lethality , 2011, The Journal of Immunology.

[47]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[48]  R. Uchiyama,et al.  Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges , 2012, Mucosal Immunology.

[49]  Gabriel Núñez,et al.  The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. , 2008, Cancer research.

[50]  N. Beauchemin,et al.  Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. , 2010, Immunity.

[51]  Gérard Eberl,et al.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis , 2008, Nature.

[52]  G. Núñez,et al.  NLRC4-driven interleukin-1β production discriminates between pathogenic and commensal bacteria and promotes host intestinal defense , 2012, Nature Immunology.

[53]  Tomohiro Watanabe,et al.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. , 2008, The Journal of clinical investigation.

[54]  D. Jewell,et al.  Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. , 2005, Human molecular genetics.

[55]  R. Vance,et al.  Innate immune recognition of bacterial ligands by NAIPs dictates inflammasome specificity , 2011, Nature.

[56]  C. Streutker,et al.  Nod1 and Nod2 Regulation of Inflammation in the Salmonella Colitis Model , 2010, Infection and Immunity.